Jpmorgan Chase & Co »

Tempest Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Tempest Therapeutics (TPST) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Tempest Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tempest Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tempest Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $484 110 4.40
2023-09-30 $1 6 0.33
2023-03-31 $1.0k 313 3.19
2022-03-31 $0 132 0.00